Point72 Asset Management L.P. Takes $850,000 Position in Fresenius Medical Care AG (NYSE:FMS)

Point72 Asset Management L.P. purchased a new stake in Fresenius Medical Care AG (NYSE:FMS - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 37,539 shares of the company's stock, valued at approximately $850,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in FMS. JPMorgan Chase & Co. raised its stake in shares of Fresenius Medical Care by 18.2% in the third quarter. JPMorgan Chase & Co. now owns 9,902 shares of the company's stock worth $211,000 after acquiring an additional 1,528 shares during the last quarter. Crossmark Global Holdings Inc. raised its position in Fresenius Medical Care by 2.2% in the 4th quarter. Crossmark Global Holdings Inc. now owns 64,287 shares of the company's stock worth $1,456,000 after purchasing an additional 1,398 shares during the last quarter. Blue Trust Inc. lifted its holdings in Fresenius Medical Care by 15.6% during the 4th quarter. Blue Trust Inc. now owns 14,876 shares of the company's stock worth $317,000 after buying an additional 2,013 shares in the last quarter. DAVENPORT & Co LLC boosted its position in Fresenius Medical Care by 1.5% in the 4th quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock valued at $1,316,000 after buying an additional 862 shares during the last quarter. Finally, Yousif Capital Management LLC bought a new position in Fresenius Medical Care in the 4th quarter valued at $208,000. Institutional investors and hedge funds own 8.37% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on FMS shares. Morgan Stanley reaffirmed an "underweight" rating on shares of Fresenius Medical Care in a research note on Thursday, May 15th. Truist Financial increased their price objective on shares of Fresenius Medical Care from $25.00 to $30.00 and gave the company a "hold" rating in a report on Monday, May 12th. Finally, Wall Street Zen began coverage on shares of Fresenius Medical Care in a report on Tuesday, May 20th. They set a "strong-buy" rating for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Fresenius Medical Care currently has an average rating of "Hold" and an average target price of $27.80.

Fresenius Medical Care Trading Down 1.6%

Shares of Fresenius Medical Care stock traded down $0.47 during trading on Wednesday, hitting $29.03. 163,555 shares of the company were exchanged, compared to its average volume of 326,542. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The firm has a market capitalization of $17.03 billion, a P/E ratio of 24.00, a price-to-earnings-growth ratio of 0.76 and a beta of 0.85. The firm's fifty day moving average price is $25.71 and its 200 day moving average price is $24.13. Fresenius Medical Care AG has a 1-year low of $17.93 and a 1-year high of $30.46.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.43 by $0.01. The firm had revenue of $5.54 billion during the quarter, compared to the consensus estimate of $4.71 billion. Fresenius Medical Care had a net margin of 3.43% and a return on equity of 6.04%. As a group, sell-side analysts expect that Fresenius Medical Care AG will post 1.51 earnings per share for the current fiscal year.

Fresenius Medical Care Increases Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Investors of record on Friday, May 23rd will be paid a dividend of $0.7871 per share. This represents a yield of 1.9%. The ex-dividend date is Friday, May 23rd. This is an increase from Fresenius Medical Care's previous annual dividend of $0.44. Fresenius Medical Care's dividend payout ratio (DPR) is presently 49.11%.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.